IP Library Assignment 058653/0651
Patent Assignment
Reel/Frame 058653/0651

Assignment of Assignor's Interest

Recorded: 2022-01-13 Pages: 3
Assignor
PHARMACEUTICAL CONSULTING LLC
Executed: 2019-04-08
Assignee
IMPEL NEUROPHARMA, INC.
201 ELLIOTT AVENUE WEST, SUITE 260, SEATTLE, WASHINGTON, 98119
Covered Property (1)
Intranasal Delivery of Olanzapine by Precision Olfactory Device
Application: 17/574,511 →
Publication: US 2022/0183965
Related Assignments (10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 13, 2022
From: DAS, ADITYA R.
To: PHARMACEUTICAL CONSULTING LLC
Reel/Frame 058653/0645 →
Assignment of Assignor's Interest Jan 13, 2022
From: HOEKMAN, JOHN D.; SATTERLY, KELSEY H.; DASHEVSKY, INNA
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 058653/0648 →
Security Interest Mar 17, 2022
From: IMPEL NEUROPHARMA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059300/0390 →
Change of Name Apr 25, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059790/0722 →
Corrective Assignment to Correct the Removal of Application Numbers 12866448 and Aplication Number 14292481 Previously Recorded at Reel: 059790 Frame: 0722. Assignor(S) Hereby Confirms the Assignment. May 4, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059855/0252 →
Assignment of Assignor's Interest Feb 15, 2024
From: IMPEL PHARMACEUTICALS INC.
To: JN BIDCO LLC
Reel/Frame 066601/0479 →
Release of Security Interest Feb 28, 2024
From: OAKTREE FUND ADMINISTRATION, LLC
To: IMPEL PHARMACEUTICALS, INC.
Reel/Frame 066699/0566 →
Security Interest Mar 20, 2024
From: JN BIDCO LLC
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 066837/0144 →
Assignment of Assignor's Interest Apr 10, 2024
From: JN BIDCO LLC
To: WOODWARD SPECIALTY LLC
Reel/Frame 067062/0344 →
Security Interest Jun 5, 2025
From: WOODWARD SPECIALTY LLC
To: ALTER DOMUS (US) LLC
Reel/Frame 071324/0602 →